Loading company details...
Latest Form 4 (Nov 18, 2025): Samuel Rubinstein (Director): Sale of 5,500 shares, $7.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 18, 2025 | Samuel Rubinstein | Sale | 5,500 | $7.3K |
| May 15, 2025 | Shmuel Gov, Chief Operating Officer | Grant/Award | 40,000 | n/a |
| May 15, 2025 | John T. Gillings, Chief Accounting Officer | Grant/Award | 30,000 | n/a |
| May 15, 2025 | Dolev Rafaeli, Chief Executive Officer | Grant/Award | 58,000 | n/a |
| Oct 30, 2024 | Christina L. Allgeier | Grant/Award | 20,000 | n/a |
| Jul 17, 2024 | Uri Geiger | Purchase | 230,573 | $724.0K |
| Jul 17, 2024 | Accelmed Partners, L.P. | Purchase | 230,573 | $724.0K |
| Jul 17, 2024 | Dolev Rafaeli, Chief Executive Officer | Purchase | 19,100 | $60.0K |
| Dec 5, 2023 | Shmuel Gov, COO | Purchase | 14,338 | $6.3K |
| Nov 22, 2023 | Shmuel Gov, COO | Grant/Award | 416,250 | n/a |